我要投票 承慶堂在医疗器械行业中的票数:235
· 外 推 电 报 ·
2025-04-27 03:59:08 星期日

【承慶堂是哪个国家的品牌?】

承慶堂是什么牌子?「承慶堂」是 安徽承庆堂国药股份有限公司 旗下著名品牌。该品牌发源于安徽省亳州市,由创始人李整风在2012-01-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力承慶堂品牌出海!通过在本页面挂载承慶堂品牌的产品链接和联系方式,可以提高承慶堂产品曝光!跨境电商爆单神器,目前只要100元/年哦~

安徽承庆堂国药股份有限公司(原亳州正丰医药有限责任公司)是于2001年投资建设的集医疗器械生产与销售一体化公司,是一家集医疗器械的技术研发、技术咨询为产业核心,采用国际OEM模式,以掌控知识产权为入手、以医药科研为主的企业,主打“承庆堂”骨病系列外用贴剂产品,以疗效显著、品质稳定深得广大骨科医院及消费者的认可和好评。公司在医药行业经过短短几年的发展历程,依靠自身产品的绝对疗效已形成了骨病系列外用贴剂的知名品牌。“品质决定品牌”,创造骨病系列外用贴剂的医药品牌是正丰医药人孜孜不倦和执着追求的目标。

公司拥有一支团结、创新、奋进的技术研发队伍,在公司全体员工的共同努力下,企业坚持走专业化道路,形成了“材料来源基地化,检测手段科学化,制作工艺规范化,贴剂质量标准化,设计包装规格化”的“五化”管理模式,产品“选料上乘,工艺考究,疗效显著”。提升了“承庆堂”品牌的知名度和美誉度。始终坚持靠诚信打造自身品牌、靠质量占领市场先机、靠服务赢得行业机遇、靠管理推动企业发展的理念,在严峻的医药行业形势下,注重发挥自身优势,做大做强主营业务,我们坚信“一生只做一件事”,在同行业内取得了骄人的业绩,公司在发展过程中,得到了各级领导和相关职能管理部门的正确指引和极大的关怀,在广大医药流通企业和商业客户的支持下,在全国药业行业中,凭借自身实力和产品品质,铸就了企业在医药行业及广大骨科医院的巩固地位。目前,公司已与国内多家骨科医院和众多客户建立了紧密、稳固的合作关系,形成了强大的销售网络和品牌优势。公司也一直专注于现代企业制度的建设,目前已经在企业的产权结构、运营模式、管理制度、业务流程上达到了一定水平,并形成了自己的特色。

公司自2007年就尝试运作终端销售模式,即在有条件的骨科医院设立精品药房,截至目前已在国内多家骨科医院建立了上百家精品药房,此模式的成功运作,有利于实现名企、名院、名医、名品的优化组合,扩大医疗机构的服务范围,为患者提供疗效显著、价格合理的诚信医疗服务。我们诚邀各大骨科医院垂询来访,共筑合作平台,实现医药携手共赢发展。

在如今医药行业新的竞争和挑战中,我们将拥有更加广阔的医药市场。“海内存知己,天涯若比邻”,公司愿与全国各大骨科医院、连锁药房及各界的朋友真诚合作、共创辉煌!



英文翻译:Anhui chengqingtang State Pharmaceutical Co., Ltd. (formerly Bozhou Zhengfeng Pharmaceutical Co., Ltd.) is an integrated production and sales company of medical devices invested and constructed in 2001. It is an enterprise that focuses on technical research and development and technical consultation of medical devices, adopts the international OEM mode, controls intellectual property rights and focuses on medical research, and focuses on "chengqingtang" osteopathy A series of external patch products, with remarkable curative effect and stable quality, have won the recognition and praise of orthopedic hospitals and consumers. After just a few years of development in the pharmaceutical industry, relying on the absolute efficacy of its own products, the company has formed a well-known brand of bone disease series external patches. "Quality determines the brand" and creating a brand of external use of orthopedic patches is the goal of Zhengfeng pharmaceutical people. The company has a united, innovative and progressive technology research and development team. With the joint efforts of all employees, the company adheres to the path of specialization, forming a "five chemical" management mode of "base of material sources, scientific detection means, standardized production process, standardized paste quality, standardized design and packaging". The product "selects the best materials, exquisite technology, and curative effect" Remarkable. It has improved the popularity and reputation of chengqingtang brand. We always adhere to the concept of building our own brand by integrity, seizing the market opportunity by quality, winning industry opportunities by service, and promoting enterprise development by management. Under the severe situation of the pharmaceutical industry, we pay attention to giving full play to our own advantages and making our main business bigger and stronger. We firmly believe that "only one thing in life" has made remarkable achievements in the same industry. In the process of development, the company has obtained With the correct guidance and great care of leaders at all levels and relevant functional management departments, supported by the majority of pharmaceutical circulation enterprises and commercial customers, and with its own strength and product quality in the national pharmaceutical industry, the company has established a firm position in the pharmaceutical industry and the majority of orthopedic hospitals. At present, the company has established close and stable cooperative relations with many orthopedic hospitals and customers in China, forming a strong sales network and brand advantages. The company has also been focusing on the construction of modern enterprise system. At present, it has reached a certain level in the property right structure, operation mode, management system and business process of the enterprise, and has formed its own characteristics. Since 2007, the company has tried to operate terminal sales mode, that is, to set up boutique pharmacies in conditional orthopedic hospitals. Up to now, hundreds of boutique pharmacies have been set up in many orthopedic hospitals in China. The successful operation of this mode is conducive to the realization of the optimized combination of famous enterprises, famous hospitals, famous doctors and famous products, the expansion of the service scope of medical institutions, and the provision of significant curative effect and reasonable price for patients The integrity of medical services. We sincerely invite all orthopedic hospitals to visit us and build a cooperation platform to achieve win-win development of medicine. In today's new competition and challenges in the pharmaceutical industry, we will have a broader pharmaceutical market. "Friends in the sea, the end of the world is like a neighbor", the company is willing to sincerely cooperate with all major orthopedic hospitals, chain pharmacies and friends from all walks of life to create brilliant!

本文链接: https://www.waitui.com/brand/8a4ae9536.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

全球首个商用智算昇腾超节点正式发布

4月26日,中国电信粤港澳大湾区智算昇腾超节点发布会,在韶关数据中心集群——中国电信粤港澳大湾区智算中心举行,全球首个商用智算昇腾超节点正式发布。(界面)

2小时前

科大讯飞发布新一代智慧课堂解决方案

4月25日,在AI赋能基础教育教学变革学术交流大会暨第五届教育装备学术大会上,科大讯飞副总裁周佳峰正式发布新一代智慧课堂解决方案,包括更新后的“星火教师助手”“AI黑板”和“AI学伴”。其中上线后的 AI 学伴,覆盖课前预习、课中学习、课后复习、精准备考、家校共育等全场景。

2小时前

全球首款三涵道穿戴式单人飞行器在杭州成功首飞

国内首创基于三涵道构型的穿戴式单人飞行器在杭州成功首飞。该飞行器由杭州智元研究院研发,续航里程≥8km,最大飞行高度≥1km,续航时间≥20min,最大速度≥60km/h。杭州智元研究院高级工程师田聪玲介绍,其采用涵道动力与舵面融合控制,有高效、可靠的特点。在人机交互方面,该飞行器可配合AR头盔和摇杆操作实现智能交互,在自动驾驶状态下能解放双手,实现高空作业。从应用看,其可应用于应急救援、飞行体验、低空经济空中作业等场景。(财联社)

2小时前

美国电商平台集体提价

近期特朗普关税政策导致全球贸易紧张局势加剧,商家运营成本上升。据美国媒体4月25日报道,美国亚马逊等电商平台上不少商家已经开始提高商品的售价。根据一家价格分析机构提供的数据,自4月9日以来,美国亚马逊网站上近1000种商品的价格出现明显上涨,涵盖服装、家居用品、电子产品和玩具等多个类别,平均涨价幅度接近30%。包括Temu、希音等多个跨境电商平台均已发布公告称,由于“近期全球贸易规则及关税变动”导致运营成本上升,将从4月25日开始实施价格调整。社交媒体上也有大量美国网友感叹道,一夜之间购物车里的东西都变贵了。 (央视财经)

2小时前

新版国家卫生监督抽查计划发布 首次明确打击网络“医托”

国家疾控局等3部门近日联合发布医疗卫生领域《2025年国家随机监督抽查计划》。相较于2024年计划,2025年计划在监管范围等方面作出调整,新增互联网诊疗、精神卫生等监管领域,并首次明确打击网络“医托”等新型违法行为,进一步强化公共卫生和医疗秩序治理。(财联社)

2小时前

本页详细列出关于承慶堂的品牌信息,含品牌所属公司介绍,承慶堂所处行业的品牌地位及优势。
咨询